A retrospective study of Tisagenlecleucel CAR-T cell therapy in secondary central nervous system lymphoma
Latest Information Update: 23 Jul 2019
At a glance
- Drugs Tisagenlecleucel (Primary)
- Indications Lymphoma
- Focus Therapeutic Use
Most Recent Events
- 23 Jul 2019 New trial record
- 18 Jul 2019 Results assessing activity of tisagenlecleucel in a heavily pretreated population published in the Blood.